Gadoxetic acid: Difference between revisions
No edit summary |
m (Protected "Gadoxetic acid": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
(No difference)
|
Latest revision as of 16:24, 20 August 2015
WikiDoc Resources for Gadoxetic acid |
Articles |
---|
Most recent articles on Gadoxetic acid Most cited articles on Gadoxetic acid |
Media |
Powerpoint slides on Gadoxetic acid |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Gadoxetic acid at Clinical Trials.gov Trial results on Gadoxetic acid Clinical Trials on Gadoxetic acid at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Gadoxetic acid NICE Guidance on Gadoxetic acid
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Gadoxetic acid Discussion groups on Gadoxetic acid Patient Handouts on Gadoxetic acid Directions to Hospitals Treating Gadoxetic acid Risk calculators and risk factors for Gadoxetic acid
|
Healthcare Provider Resources |
Causes & Risk Factors for Gadoxetic acid |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Gadoxetic acid is a gadolinium-based MRI contrast agent. Its salt, gadoxetate disodium, is marketed as Primovist in Europe and Eovist in the United States by Bayer HealthCare Pharmaceuticals.[1]
References
- ↑ "Eovist - Homepage". Retrieved 2009-03-22.